Heather Elliott
Family · Rocky Ford, CONPI 1003233479
Payments from drug & device makers
Across 113 payments — averaging $18.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$727
- AstraZeneca$211
- Novo Nordisk$209
- Pfizer$203
- Lilly USA, LLC$175
- Otsuka America Pharmaceutical, Inc.$135
- plus $458 from 11 others
What the payments were for
- Food & beverage$2,10699%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $727 |
| AstraZeneca | 13 | $211 |
| Novo Nordisk | 6 | $209 |
| Pfizer | 10 | $203 |
| Lilly USA, LLC | 10 | $175 |
| Otsuka America Pharmaceutical, Inc. | 6 | $135 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $101 |
| Amgen | 5 | $92 |
| Alkermes, Inc. | 2 | $61 |
| Idorsia Pharmaceuticals US Inc | 3 | $59 |
| Harmony Biosciences LLC | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $24 |
| Edwards Lifesciences | 1 | $19 |
| Ardelyx, Inc. | 1 | $17 |
| Gilead | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Bayer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,117 in reported general payments places this provider in the 85th percentile of 2,182 family providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 100 | $100,701 |
| XifaxanRifaximin | 32 | $81,009 |
| Tresiba Flextouch U-200Insulin Degludec | 16 | $46,061 |
| EliquisApixaban | 52 | $45,025 |
| MounjaroTirzepatide | 30 | $41,857 |
| FarxigaDapagliflozin Propanediol | 48 | $41,543 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 33 | $37,771 |
| UbrelvyUbrogepant | 15 | $36,909 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 26 | $27,425 |
| VraylarCariprazine Hcl | 19 | $26,215 |
| Aimovig AutoinjectorErenumab-Aooe | 24 | $24,407 |
| RybelsusSemaglutide | 15 | $23,327 |
| MyrbetriqMirabegron | 22 | $21,395 |
| SymbicortBudesonide/Formoterol Fumarate | 60 | $19,926 |
| XareltoRivaroxaban | 31 | $17,615 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $209 | $124,028115 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort, Bevespi Aerosphere | $211 | $104,441153 claims |
| AbbVieUbrelvy, Vraylar, Qulipta, Synthroid | $727 | $77,39271 claims |
| PfizerEliquis, Premarin | $203 | $53,64975 claims |
| Lilly USA, LLCMounjaro | $175 | $41,85730 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,182 family providers in Colorado.
Other family in Rocky Ford
- Laura GrahamLakewood$1.6M
- Corinne YoungColorado Springs$272K
- Margaret MachaffieColorado Springs$97K
- April RossGrand Junction$95K
- Jeannette LillerColorado Springs$74K
- Teal MeffordThornton$63K
- Jacquita JordanColorado Springs$52K
- Stephanie HanenbergColorado Springs$40K
- Courtney WeirFort Collins$30K
- Katie NadingDenver$28K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.